Cargando…

Multimorbidity and Complex Multimorbidity in India: Findings from the 2017–2018 Longitudinal Ageing Study in India (LASI)

Complex multimorbidity refers to the co-occurrence of three or more chronic illnesses across >2 body systems, which may identify persons in need of additional medical support and treatment. There is a scarcity of evidence on the differences in patient outcomes between non-complex (≥2 conditions)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Abhinav, Kerketta, Sushmita, Ghosal, Shishirendu, Kanungo, Srikanta, Lee, John Tayu, Pati, Sanghamitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332385/
https://www.ncbi.nlm.nih.gov/pubmed/35897461
http://dx.doi.org/10.3390/ijerph19159091
_version_ 1784758633720971264
author Sinha, Abhinav
Kerketta, Sushmita
Ghosal, Shishirendu
Kanungo, Srikanta
Lee, John Tayu
Pati, Sanghamitra
author_facet Sinha, Abhinav
Kerketta, Sushmita
Ghosal, Shishirendu
Kanungo, Srikanta
Lee, John Tayu
Pati, Sanghamitra
author_sort Sinha, Abhinav
collection PubMed
description Complex multimorbidity refers to the co-occurrence of three or more chronic illnesses across >2 body systems, which may identify persons in need of additional medical support and treatment. There is a scarcity of evidence on the differences in patient outcomes between non-complex (≥2 conditions) and complex multimorbidity groups. We evaluated the prevalence and patient outcomes of complex multimorbidity and compared them to non-complex multimorbidity. We included 30,489 multimorbid individuals aged ≥45 years from the Longitudinal Ageing Study in India (LASI) from wave-1 conducted in 2017–2018. We employed a log link in generalised linear models (GLM) to identify possible risk factors presenting the adjusted prevalence–risk ratio (APRR) and adjusted prevalence–risk difference (APRD) with 95% confidence interval. The prevalence of complex multimorbidity was 34.5% among multimorbid individuals. Participants residing in urban areas [APRR: 1.10 (1.02, 1.20)], [APRD: 0.04 (0.006, 0.07)] were more likely to report complex multimorbidity. Participants with complex multimorbidity availed significantly higher inpatient department services and had higher expenditure as compared to the non-complex multimorbidity group. Our findings have major implications for healthcare systems in terms of meeting the requirements of people with complicated multimorbidity, as they have significantly higher inpatient health service utilisation, higher medical costs, and poorer self-rated health.
format Online
Article
Text
id pubmed-9332385
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93323852022-07-29 Multimorbidity and Complex Multimorbidity in India: Findings from the 2017–2018 Longitudinal Ageing Study in India (LASI) Sinha, Abhinav Kerketta, Sushmita Ghosal, Shishirendu Kanungo, Srikanta Lee, John Tayu Pati, Sanghamitra Int J Environ Res Public Health Article Complex multimorbidity refers to the co-occurrence of three or more chronic illnesses across >2 body systems, which may identify persons in need of additional medical support and treatment. There is a scarcity of evidence on the differences in patient outcomes between non-complex (≥2 conditions) and complex multimorbidity groups. We evaluated the prevalence and patient outcomes of complex multimorbidity and compared them to non-complex multimorbidity. We included 30,489 multimorbid individuals aged ≥45 years from the Longitudinal Ageing Study in India (LASI) from wave-1 conducted in 2017–2018. We employed a log link in generalised linear models (GLM) to identify possible risk factors presenting the adjusted prevalence–risk ratio (APRR) and adjusted prevalence–risk difference (APRD) with 95% confidence interval. The prevalence of complex multimorbidity was 34.5% among multimorbid individuals. Participants residing in urban areas [APRR: 1.10 (1.02, 1.20)], [APRD: 0.04 (0.006, 0.07)] were more likely to report complex multimorbidity. Participants with complex multimorbidity availed significantly higher inpatient department services and had higher expenditure as compared to the non-complex multimorbidity group. Our findings have major implications for healthcare systems in terms of meeting the requirements of people with complicated multimorbidity, as they have significantly higher inpatient health service utilisation, higher medical costs, and poorer self-rated health. MDPI 2022-07-26 /pmc/articles/PMC9332385/ /pubmed/35897461 http://dx.doi.org/10.3390/ijerph19159091 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sinha, Abhinav
Kerketta, Sushmita
Ghosal, Shishirendu
Kanungo, Srikanta
Lee, John Tayu
Pati, Sanghamitra
Multimorbidity and Complex Multimorbidity in India: Findings from the 2017–2018 Longitudinal Ageing Study in India (LASI)
title Multimorbidity and Complex Multimorbidity in India: Findings from the 2017–2018 Longitudinal Ageing Study in India (LASI)
title_full Multimorbidity and Complex Multimorbidity in India: Findings from the 2017–2018 Longitudinal Ageing Study in India (LASI)
title_fullStr Multimorbidity and Complex Multimorbidity in India: Findings from the 2017–2018 Longitudinal Ageing Study in India (LASI)
title_full_unstemmed Multimorbidity and Complex Multimorbidity in India: Findings from the 2017–2018 Longitudinal Ageing Study in India (LASI)
title_short Multimorbidity and Complex Multimorbidity in India: Findings from the 2017–2018 Longitudinal Ageing Study in India (LASI)
title_sort multimorbidity and complex multimorbidity in india: findings from the 2017–2018 longitudinal ageing study in india (lasi)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332385/
https://www.ncbi.nlm.nih.gov/pubmed/35897461
http://dx.doi.org/10.3390/ijerph19159091
work_keys_str_mv AT sinhaabhinav multimorbidityandcomplexmultimorbidityinindiafindingsfromthe20172018longitudinalageingstudyinindialasi
AT kerkettasushmita multimorbidityandcomplexmultimorbidityinindiafindingsfromthe20172018longitudinalageingstudyinindialasi
AT ghosalshishirendu multimorbidityandcomplexmultimorbidityinindiafindingsfromthe20172018longitudinalageingstudyinindialasi
AT kanungosrikanta multimorbidityandcomplexmultimorbidityinindiafindingsfromthe20172018longitudinalageingstudyinindialasi
AT leejohntayu multimorbidityandcomplexmultimorbidityinindiafindingsfromthe20172018longitudinalageingstudyinindialasi
AT patisanghamitra multimorbidityandcomplexmultimorbidityinindiafindingsfromthe20172018longitudinalageingstudyinindialasi